ARTICLE | Clinical News
Maxim Pharmaceuticals preclinical data
September 20, 1999 7:00 AM UTC
University of Umea researchers published in Anticancer Research that rat prostate tumors treated with Maxamine and IL-2 had significantly fewer prostate cancer cells than ether untreated tumors or tho...